跳至主要内容
临床试验/NCT00688610
NCT00688610已完成2 期

Antibiotics in Patients With Acute Respiratory Tract Infections in Primary Care in Consideration of Procalcitonin as Additive Parameter

Hannover Medical School2 个研究点 分布在 1 个国家目标入组 571 人开始时间: 2007年11月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
571
试验地点
2
主要终点
days with significant impairment due to acute respiratory tract infection

研究概览

简要总结

Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter.

The purpose of this study is to compare the ordinary manner of antibiotic- prescription with the prescription in consideration of procalcitonin-value in patients with acute respiratory tract infections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Informed consent
  • Respiratory tract infection based on the clinical judgement of the primary care physician

排除标准

  • Antibiotic pretreatment in previous 14 days
  • Portal hypertension
  • Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
  • Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
  • Peritoneal dialysis
  • Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
  • Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis

结局指标

主要结局

days with significant impairment due to acute respiratory tract infection

时间窗: 14 to 28 days after infection

次要结局

  • number of antibiotic prescriptions(28 days)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验